BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25866779)

  • 21. Alzheimer's disease: connecting findings from graph theoretical studies of brain networks.
    Tijms BM; Wink AM; de Haan W; van der Flier WM; Stam CJ; Scheltens P; Barkhof F
    Neurobiol Aging; 2013 Aug; 34(8):2023-36. PubMed ID: 23541878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling in Alzheimer's disease brain microvessels.
    Wang S; Qaisar U; Yin X; Grammas P
    J Alzheimers Dis; 2012; 31(1):193-205. PubMed ID: 22531426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains.
    Liu ZP; Wang Y; Zhang XS; Chen L
    BMC Syst Biol; 2010 Sep; 4 Suppl 2(Suppl 2):S11. PubMed ID: 20840725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer's disease.
    Bozzali M; Parker GJ; Serra L; Embleton K; Gili T; Perri R; Caltagirone C; Cercignani M
    Neuroimage; 2011 Feb; 54(3):2045-51. PubMed ID: 20828625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased 5S rRNA oxidation in Alzheimer's disease.
    Ding Q; Zhu H; Zhang B; Soriano A; Burns R; Markesbery WR
    J Alzheimers Dis; 2012; 29(1):201-9. PubMed ID: 22232003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A regulatory role for the insulin- and BDNF-linked RORA in the hippocampus: implications for Alzheimer's disease.
    Acquaah-Mensah GK; Agu N; Khan T; Gardner A
    J Alzheimers Dis; 2015; 44(3):827-38. PubMed ID: 25362032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
    Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
    Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
    Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a noncoding RNA‑mediated gene pair‑based regulatory module in Alzheimer's disease.
    Yu L; Qian S; Wei S
    Mol Med Rep; 2018 Aug; 18(2):2164-2170. PubMed ID: 29956760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of network based co-expression modules for Alzheimer's disease.
    Dua P; Bais S; Lukiw WJ
    Stud Health Technol Inform; 2013; 192():1227. PubMed ID: 23921001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression.
    Aubry S; Shin W; Crary JF; Lefort R; Qureshi YH; Lefebvre C; Califano A; Shelanski ML
    PLoS One; 2015; 10(3):e0120352. PubMed ID: 25781952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing.
    Alonso R; Pisa D; Aguado B; Carrasco L
    J Alzheimers Dis; 2017; 58(1):55-67. PubMed ID: 28387676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring novel mechanistic insights in Alzheimer's disease by assessing reliability of protein interactions.
    Malhotra A; Younesi E; Sahadevan S; Zimmermann J; Hofmann-Apitius M
    Sci Rep; 2015 Sep; 5():13634. PubMed ID: 26346705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation Analysis on Spatiotemporal Specific Co-expression Networks Suggests the Immunopathogenesis of Alzheimer's Disease.
    Guo L; Liu Y; Wang J
    Front Aging Neurosci; 2021; 13():727928. PubMed ID: 34539387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personalized Protein-Protein Interaction Networks Towards Unraveling the Molecular Mechanisms of Alzheimer's Disease.
    Ceylan B; Düz E; Çakir T
    Mol Neurobiol; 2024 Apr; 61(4):2120-2135. PubMed ID: 37855983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of coordinately dysregulated subnetworks in complex phenotypes.
    Chowdhury SA; Koyutürk M
    Pac Symp Biocomput; 2010; ():133-44. PubMed ID: 19908366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A computational analysis of protein-protein interaction networks in neurodegenerative diseases.
    Goñi J; Esteban FJ; de Mendizábal NV; Sepulcre J; Ardanza-Trevijano S; Agirrezabal I; Villoslada P
    BMC Syst Biol; 2008 Jun; 2():52. PubMed ID: 18570646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOBAS: identification of disease-associated protein subnetworks using modularity-based scoring.
    Ayati M; Erten S; Chance MR; Koyutürk M
    EURASIP J Bioinform Syst Biol; 2015 Dec; 2015():7. PubMed ID: 28194175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subnetwork state functions define dysregulated subnetworks in cancer.
    Chowdhury SA; Nibbe RK; Chance MR; Koyutürk M
    J Comput Biol; 2011 Mar; 18(3):263-81. PubMed ID: 21385033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.